1. Home
  2. KELYB vs AGMB Comparison

KELYB vs AGMB Comparison

Compare KELYB & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

HOLD

Current Price

$23.47

Market Cap

814.8M

ML Signal

HOLD

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$13.29

Market Cap

738.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KELYB
AGMB
Founded
1946
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
814.8M
738.7M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
KELYB
AGMB
Price
$23.47
$13.29
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$32.00
AVG Volume (30 Days)
853.0
89.6K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$5,355,600,000.00
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
$17.86
P/E Ratio
$156.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$8.75
52 Week High
$125.00
$17.82

Technical Indicators

Market Signals
Indicator
KELYB
AGMB
Relative Strength Index (RSI) 55.37 49.76
Support Level $11.66 $9.54
Resistance Level $24.78 $14.19
Average True Range (ATR) 0.55 1.05
MACD -0.18 -0.11
Stochastic Oscillator 72.88 29.81

Price Performance

Historical Comparison
KELYB
AGMB

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: